Genscript Biotech Corp
HKEX:1548

Watchlist Manager
Genscript Biotech Corp Logo
Genscript Biotech Corp
HKEX:1548
Watchlist
Price: 11 HKD 4.96% Market Closed
Market Cap: 23.1B HKD
Have any thoughts about
Genscript Biotech Corp?
Write Note

Wall Street
Price Targets

Price Targets Summary
Genscript Biotech Corp

Wall Street analysts forecast Genscript Biotech Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Genscript Biotech Corp is 24.7 HKD with a low forecast of 16.16 HKD and a high forecast of 30.59 HKD.

Lowest
Price Target
16.16 HKD
47% Upside
Average
Price Target
24.7 HKD
125% Upside
Highest
Price Target
30.59 HKD
178% Upside
Genscript Biotech Corp Competitors:
Price Targets
LONN
Lonza Group AG
18% Upside
OABI
OmniAb Inc
152% Upside
QSI
Quantum-Si Inc
114% Upside
HVO
hVIVO PLC
77% Upside
FTRE
Fortrea Holdings Inc
20% Upside
LAB
Standard BioTools Inc
84% Upside
GENO
Genovis AB
50% Upside
300463
Maccura Biotechnology Co Ltd
1% Downside

Revenue
Forecast

Revenue Estimate
Genscript Biotech Corp

For the last 8 years the compound annual growth rate for Genscript Biotech Corp's revenue is 33%. The projected CAGR for the next 3 years is 49%.

33%
Past Growth
49%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Genscript Biotech Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
20%
Average Beat

Net Income
Forecast

Net Income Estimate
Genscript Biotech Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Genscript Biotech Corp's stock price target?
Price Target
24.7 HKD

According to Wall Street analysts, the average 1-year price target for Genscript Biotech Corp is 24.7 HKD with a low forecast of 16.16 HKD and a high forecast of 30.59 HKD.

What is Genscript Biotech Corp's Revenue forecast?
Projected CAGR
49%

For the last 8 years the compound annual growth rate for Genscript Biotech Corp's revenue is 33%. The projected CAGR for the next 3 years is 49%.

Back to Top